Coronavirus updates: 1st vaccines now on the way to all 50 US states
Two main trucks left the Pfizer facility on Sunday morning, the company said.
A pandemic of the novel coronavirus has now infected more than 71.5 million people and killed over 1.6 million worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.
Latest headlines:
Germany to begin COVID-19 vaccinations in early January
COVID-19 vaccinations are expected to begin in Germany "in the very first days" of 2021, according to German Chancellor Angela Merkel’s chief of staff.
In an online interview Sunday with German newspaper Bild, Helge Braun said he and Merkel will get vaccinated "when it's our turn." The trained doctor also noted that he's prepared to help vaccinate people himself.
"That won’t work at every hour of the day or night as chief of staff, but at the weekend I’m prepared to join in," Braun told the Bild.
The European Union's drug regulator is expected to make a decision by Dec. 29 on approving the first COVID-19 vaccine for use. In the meantime, Germany is preparing special vaccination centers.
US reports over 175,000 new cases
There were 175,663 new cases of COVID-19 confirmed in the United States on Sunday, according to a real-time count kept by Johns Hopkins University.
It's the 34th straight day that the U.S. has reported over 100,000 newly diagnosed infections. Sunday's tally is less than the country's all-time high of 227,885 new cases confirmed on Dec. 4, according to Johns Hopkins data.
An additional 1,114 deaths from the disease were also registered nationwide on Sunday, down from a peak of 2,879 fatalities on Dec. 3, according to Johns Hopkins data.
COVID-19 data may be skewed due to possible lags in reporting over Thanksgiving followed by a potentially very large backlog from the holiday.
A total of 14,760,627 people in the U.S. have been diagnosed with COVID-19 since the pandemic began, and at least 282,312 of them have died, according to Johns Hopkins data. The cases include people from all 50 U.S. states, Washington, D.C., and other U.S. territories as well as repatriated citizens.
Much of the country was under lockdown by the end of March as the first wave of pandemic hit. By May 20, all U.S. states had begun lifting stay-at-home orders and other restrictions put in place to curb the spread of the novel coronavirus. The day-to-day increase in the country's cases then hovered around 20,000 for a couple of weeks before shooting back up over the summer.
The numbers lingered around 40,000 to 50,000 from mid-August through early October before surging again to record levels, crossing 100,000 for the first time on Nov. 4 and reaching 200,000 for the first time on Nov. 27.
FDA ‘very comfortable’ with vaccine safety profile for 16, 17 year olds
Common questions surrounding the newly authorized Pfizer vaccine include safety for teenagers and the risk of allergic reactions.
Though the final data doesn’t have conclusive data on 16 and 17 year olds because they weren’t enrolled in trials until more recently, the FDA is “very comfortable with the safety profile that was observed in 17 and 16 year olds," Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, told reporters.
Regarding allergies, Marks said 1.6% of the population has had a severe allergic reaction.
Marks said you should notify your doctor if you’ve ever had an allergic reaction to a vaccine and noted that sites that administer the vaccine will have medications on hand to respond to an allergic reaction.
ABC News’ Anne Flaherty contributed to this report.